Global Dental sleep medicine Market Analysis & Forecast To 2023

The global dental sleep medicine market was valued at $ 6,250.00 million in 2016 and expected to reach at $ 10,851.03 million by 2027 at a CAGR of 8.2 % during the forecast period.

Reference: 180050
Price: $4,450.00
Tax included

General

Geography Covered
Global
Publisher:
Market Research Future
Publication Date
Mar. 2017
Pages
83
Version:
2017
Language
  • English
Format
License

The global dental sleep medicine market was valued at $ 6,250.00 million in 2016 and expected to reach at $ 10,851.03 million by 2027 at a CAGR of 8.2 % during the forecast period. The most important factor for the rise in market is the huge number of unmet medical needs and the rising awareness of sleep disorders and the growing rate of screening for the ailment. The other market drivers are related with modern lifestyles such as lack of exercise, long working hours and exposure to noise and light pollution.

The market is majorly categorized on the basis of treatment & diagnostics which is further segmented into treatment and diagnostics. On the basis of treatment the market is segmented into positive airway pressure (PAP) therapy, oral and nasal devices, airway systems, other devices, drugs, and surgery. On the basis of diagnostics the market is segmented into polysomnography and respiratory polygraphy and home oximetry and actigraph. On the basis of end users the market is segmented into hospitals and sleep laboratories, and home and geographic regions. Globally, North America holds the largest market share of global dental sleep medicine market, registering 56.4% % in 2016.
The scope of global dental sleep medicine market study includes the market value, market size and a detailed analysis of vendor products and strategies.
Key Players
The leading players of the global dental sleep medicine market are Koninklijke Philips N.V., ResMed, Fisher & Paykel Healthcare, Drive DeVilbiss Healthcare, Curative Medical Inc., Apex Medical Corporation, BMC Medical Co. Ltd., Becton, Dickinson and Company and others.
Study Objectives of Dental sleep medicine Market Development and Demand Forecast to 2027 Market
 To provide insights about factors, influencing and affecting the market growth
 To provide historically and forecast revenue of the market segments and sub-segments with respect to regional markets and their countries
 To provide historically and forecast revenue of the market segments based on type, and sub-segment for global dental sleep medicine market
 To provide strategic profiling of key players in the market, comprehensively analyzing their market share, core competencies, and drawing a competitive landscape for the market
 To provide economic factors that influence the global dental sleep medicine market

Target Audience
• Dental sleep medicine companies
• Hospitals & Clinics
• Raw Material Suppliers
• Key executive (CEO and COO) and strategy growth manager
Key Findings
• On the basis of treatment, the positive airway pressure (PAP) therapy dominates the segment with a share of 39.97% and growing with a CAGR of 9.24%.
• U.S. accounted for the largest market share of 85.00 % in 2016, which is expected to grow at a CAGR of 9.82 % during the forecast period from 2016 to 2023.

The reports also cover country level analysis:
• North America
• US
• Canada
• Europe
• Western Europe
• Germany
• France
• U.K.
• Italy
• Spain
• Rest of Western Europe
• Eastern Europe
• Asia-Pacific
• China
• Japan
• India
• Republic of Korea
• Rest of Asia-Pacific
• Middle East & Africa

1 Report Prologue 9
2 Introduction 12
2.1 Scope of Study 12
2.2 Research Objective 12
2.3 Assumptions & Limitations 13
2.3.1 Assumptions 13
2.3.2 Limitations 13
2.4 Market Structure 13
3 Research Methodology 14
3.1 Research Process 14
3.2 Primary Research 15
3.3 Secondary Research 15
4 Market Factor Analysis 16
4.1 Porter’s Five Force Analysis 16
4.1.1 Bargaining Power of Buyer 17
4.1.2 Bargaining Power of Supplier 17
4.1.3 Threat from Substitute 18
4.1.4 Threat from a New Entrant 18
4.1.5 Intensity of Competitive Rivalry 18
4.2 Value Chain Analysis 19
4.2.1 Device Manufacturers 19
4.2.2 Software Developers 19
4.2.3 Healthcare Providers 19
4.2.4 Patients 19
5 Market Dynamics 20
5.1 Introduction 20
5.2 Drivers 21
5.2.1 Rise in risk factors is propelling the market growth 21
5.2.2 Rise in diseases and growing geriatrics population 21
5.2.3 Unmet needs 21
5.2.4 Growing awareness of sleep disorders 21
5.2.5 Technological advancements 22
5.3 Restraints 22
5.3.1 High cost and scanty presence of sleep labs 22
5.3.2 Late awareness and discomfort 22
5.3.3 Long-term dental changes 23
5.3.4 Lack of effectiveness and efficacy 23
5.4 Opportunities 23
5.4.1 Untapped market 23
5.4.2 Research and development 23
5.4.3 Personalized and customised solutions 24
5.4.4 Connected solutions and cloud based systems 24
5.5 Challenges 24
5.5.1 Poor standardization 24
5.5.2 Sub-standard products 25
6 Global Dental Sleep Medicine Market, By Treatment & Diagnostics 26
6.1 Introduction 26
6.2 Treatments 28
6.3 Diagnostics 29
7 Global Dental Sleep Medicine Market, By End Users 30
7.1 Introduction 30
7.2 Hospitals & Sleep Laboratories 31
7.3 Home 32
8 Global Dental Sleep Medicine Market, By Region 33
8.1 Introduction 33
8.2 North America 34
8.2.1 U.S. 36
8.2.2 Canada 38
8.3 Europe 39
8.3.1 Germany 41
8.3.2 France 43
8.3.3 U.K. 44
8.3.4 Italy 46
8.3.5 Spain 47
8.3.6 Rest of Europe 49
8.4 Asia Pacific 50
8.4.1 Japan 53
8.4.2 China 54
8.4.3 India 56
8.4.4 Australia 57
8.4.5 Republic of Korea 59
8.4.6 Rest of Asia Pacific 60
8.5 Middle East and Africa 62
8.5.1 Middle East 64
8.5.2 Africa 66
9 Company Profiling 68
9.1 Koninklijke Philips N.V. 68
9.1.1 Company Overview 68
9.1.2 Financial Overview 69
9.1.3 Key Developments 70
9.1.4 SWOT Analysis 71
9.2 ResMed 72
9.2.1 Company Overview 72
9.2.2 Financial Overview 72
9.2.3 Key Developments 73
9.2.4 SWOT Analysis 73
9.3 Fisher & Paykel Healthcare 74
9.3.1 Company Overview 74
9.3.2 Financial Overview 74
9.3.3 Key Developments 75
9.3.4 SWOT Analysis 75
9.4 Drive DeVilbiss Healthcare 76
9.4.1 Company Overview 76
9.4.2 Financial Overview 76
9.4.3 Key Developments 76
9.4.4 SWOT Analysis 77
9.5 Curative Medical Inc. 78
9.5.1 Company Overview 78
9.5.2 Financial Overview 78
9.5.3 Key Development 78
9.5.4 SWOT Analysis 79
9.6 Apex Medical Corporation 80
9.6.1 Company Overview 80
9.6.2 Financial Overview 80
9.6.3 Key Developments 80
9.7 BMC Medical Co. Ltd. 81
9.7.1 Company Overview 81
9.7.2 Financial Overview 81
9.8 Becton, Dickinson and Company 82
9.8.1 Company Overview 82
9.8.2 Financial Overview 82
9.8.3 Key Developments 82

TABLE 1 GLOBAL DENTAL SLEEP MEDICINE MARKET, BY TREATMENT AND DIAGNOSTICS, 2014-2023 (USD MILLION) 27
TABLE 2 GLOBAL DENTAL SLEEP MEDICINE TREATMENT MARKET, BY REGION, 2014-2023 (USD MILLION) 28
TABLE 3 GLOBAL DENTAL SLEEP MEDICINE DIAGNOSTICS MARKET, BY REGION, 2014-2023 (USD MILLION) 29
TABLE 4 GLOBAL DENTAL SLEEP MEDICINE MARKET, BY END USERS, 2014-2023 (USD MILLION) 30
TABLE 5 GLOBAL DENTAL SLEEP MEDICINE HOSPITALS AND SLEEP LABORATORIES MARKET, BY REGION,
2014-2023 (USD MILLION) 31
TABLE 6 GLOBAL DENTAL SLEEP MEDICINE HOME MARKET, BY REGION, 2014-2023 (USD MILLION) 32
TABLE 7 GLOBAL DENTAL SLEEP MEDICINE MARKET, BY REGION, 2014-2023 (USD MILLION) 33
TABLE 8 NORTH AMERICA DENTAL SLEEP MEDICINE MARKET, BY COUNTRY, 2014-2023 (USD MILLION) 34
TABLE 9 NORTH AMERICA DENTAL SLEEP MARKET, BY TREATMENT AND DIAGNOSTICS, 2014-2023 (USD MILLION) 35
TABLE 10 NORTH AMERICA DENTAL SLEEP MEDICINE MARKET, BY END USERS, 2014-2023 (USD MILLION) 36
TABLE 11 U.S. DENTAL SLEEP MEDICINE MARKET, BY TREATMENT AND DIAGNOSTICS, 2014-2023 (USD MILLION) 36
TABLE 12 U.S. DENTAL SLEEP MEDICINE MARKET, BY END USERS, 2014-2023 (USD MILLION) 37
TABLE 13 CANADA DENTAL SLEEP MEDICINE MARKET, BY TREATMENT AND DIAGNOSTICS, 2014-2023 (USD MILLION) 38
TABLE 14 CANADA DENTAL SLEEP MEDICINE MARKET, BY END USERS, 2014-2023 (USD MILLION) 39
TABLE 15 EUROPE DENTAL SLEEP MEDICINE MARKET, BY COUNTRY, 2014-2023 (USD MILLION) 39
TABLE 16 EUROPE DENTAL SLEEP MEDICINE MARKET, BY TREATMENT AND DIAGNOSTICS, 2014-2023 (USD MILLION) 40
TABLE 17 EUROPE DENTAL SLEEP MEDICINE MARKET, BY END USERS, 2014-2023 (USD MILLION) 41
TABLE 18 GERMANY DENTAL SLEEP MEDICINE MARKET, BY TREATMENT AND DIAGNOSTICS,
2014-2023 (USD MILLION) 41
TABLE 19 GERMANY DENTAL SLEEP MEDICINE MARKET, BY END USERS, 2014-2023 (USD MILLION) 42
TABLE 20 FRANCE DENTAL SLEEP MEDICINE MARKET, BY TREATMENT AND DIAGNOSTICS, 2014-2023 (USD MILLION) 43
TABLE 21 FRANCE DENTAL SLEEP MEDICINE MARKET, BY END USERS, 2014-2023 (USD MILLION) 44
TABLE 22 U.K. DENTAL SLEEP MEDICINE MARKET, BY TREATMENT AND DIAGNOSTICS, 2014-2023 (USD MILLION) 44
TABLE 23 U.K DENTAL SLEEP MEDICINE MARKET, BY END USERS, 2014-2023 (USD MILLION) 45
TABLE 24 ITALY DENTAL SLEEP MEDICINE MARKET, BY TREATMENT AND DIAGNOSTICS, 2014-2023 (USD MILLION) 46
TABLE 25 ITALY DENTAL SLEEP MEDICINE MARKET, BY END USERS, 2014-2023 (USD MILLION) 47
TABLE 26 SPAIN DENTAL SLEEP MEDICINE MARKET, BY TREATMENT AND DIAGNOSTICS, 2014-2023 (USD MILLION) 47
TABLE 27 SPAIN DENTAL SLEEP MEDICINE MARKET, BY END USERS, 2014-2023 (USD MILLION) 48
TABLE 28 REST OF EUROPE DENTAL SLEEP MEDICINE MARKET, BY TREATMENT AND DIAGNOSTICS,
2014-2023 (USD MILLION) 49
TABLE 29 REST OF EUROPE DENTAL SLEEP MEDICINE MARKET, BY END USERS, 2014-2023 (USD MILLION) 50
TABLE 30 ASIA PACIFIC DENTAL SLEEP MEDICINE MARKET, BY COUNTRY, 2014-2023 (USD MILLION) 50
TABLE 31 ASIA PACIFIC DENTAL SLEEP MEDICINE MARKET, BY TREATMENT AND DIAGNOSTICS, 2014-2023 (USD MILLION) 51
TABLE 32 ASIA PACIFIC DENTAL SLEEP MEDICINE MARKET, BY END USERS, 2014-2023 (USD MILLION) 52
TABLE 33 JAPAN DENTAL SLEEP MEDICINE MARKET, BY TREATMENT AND DIAGNOSTICS, 2014-2023 (USD MILLION) 53
TABLE 34 JAPAN DENTAL SLEEP MEDICINE MARKET, BY END USERS, 2014-2023 (USD MILLION) 54
TABLE 35 CHINA DENTAL SLEEP MEDICINE MARKET, BY TREATMENT AND DIAGNOSTICS, 2014-2023 (USD MILLION) 54
TABLE 36 CHINA DENTAL SLEEP MEDICINE MARKET, BY END USERS, 2014-2023 (USD MILLION) 55
TABLE 37 INDIA DENTAL SLEEP MEDICINE MARKET, BY TREATMENT AND DIAGNOSTICS, 2014-2023 (USD MILLION) 56
TABLE 38 INDIA DENTAL SLEEP MEDICINE MARKET, BY END USERS, 2014-2023 (USD MILLION) 57
TABLE 39 AUSTRALIA DENTAL SLEEP MEDICINE MARKET, BY TREATMENT AND DIAGNOSTICS,
2014-2023 (USD MILLION) 57
TABLE 40 AUSTRALIA DENTAL SLEEP MEDICINE MARKET, BY END USERS, 2014-2023 (USD MILLION) 58
TABLE 41 REPUBLIC OF KOREA DENTAL SLEEP MEDICINE MARKET, BY TREATMENT AND DIAGNOSTICS,
2014-2023 (USD MILLION) 59
TABLE 42 REPUBLIC OF KOREA DENTAL SLEEP MEDICINE MARKET, BY END USERS, 2014-2023 (USD MILLION) 60
TABLE 43 REST OF ASIA PACIFIC DENTAL SLEEP MEDICINE MARKET, BY TREATMENT AND DIAGNOSTICS,
2014-2023 (USD MILLION) 60
TABLE 44 REST OF ASIA PACIFIC DENTAL SLEEP MEDICINE MARKET, BY END USERS, 2014-2023 (USD MILLION) 61
TABLE 45 MIDDLE EAST AND AFRICA DENTAL SLEEP MEDICINE MARKET, BY COUNTRY, 2014-2023 (USD MILLION) 62
TABLE 46 MIDDLE EAST AND AFRICA DENTAL SLEEP MEDICINE MARKET, BY TREATMENT AND DIAGNOSTICS,
2014-2023 (USD MILLION) 63
TABLE 47 MIDDLE EAST AND AFRICA DENTAL SLEEP MEDICINE MARKET, BY END USERS, 2014-2023 (USD MILLION) 64
TABLE 48 MIDDLE EAST DENTAL SLEEP MEDICINE MARKET, BY TREATMENT AND DIAGNOSTICS,
2014-2023 (USD MILLION) 64
TABLE 49 MIDDLE EAST DENTAL SLEEP MEDICINE MARKET, BY END USERS, 2014-2023 (USD MILLION) 65
TABLE 50 AFRICA DENTAL SLEEP MEDICINE MARKET, BY TREATMENT AND DIAGNOSTICS, 2014-2023 (USD MILLION) 66
TABLE 51 AFRICA DENTAL SLEEP MEDICINE MARKET, BY END USERS, 2014-2023 (USD MILLION) 67
TABLE 52 PHILIPS RESPIRONICS: PRODUCT/BUSINESS SEGMENT OVERVIEW 68
TABLE 53 PHILIPS RESPIRONICS: KEY DEVELOPMENTS 70
TABLE 54 RESMED: PRODUCT/BUSINESS SEGMENT OVERVIEW 72
TABLE 55 RESMED: KEY DEVELOPMENTS 73
TABLE 56 FISHER & PAYKEL HEALTHCARE: PRODUCT/BUSINESS SEGMENT OVERVIEW 74
TABLE 57 FISHER & PAYKEL HEALTHCARE: KEY DEVELOPMENTS 75
TABLE 58 DEVILBISS HEALTHCARE: PRODUCT/BUSINESS SEGMENT OVERVIEW 76
TABLE 59 CURATIVE MEDICAL INC.: PRODUCT/BUSINESS SEGMENT OVERVIEW 78
TABLE 60 CURATIVE MEDICAL INC.: KEY DEVELOPMENT 78
TABLE 61 APEX MEDICAL CORPORATION: PRODUCT/BUSINESS SEGMENT OVERVIEW 80
TABLE 62 APEX MEDICAL CORPORATION: KEY DEVELOPMENTS 80
TABLE 63 BMC MEDICAL CO. LTD.: PRODUCT/BUSINESS SEGMENT OVERVIEW 81
TABLE 64 BECTON, DICKINSON AND COMPANY: PRODUCT/BUSINESS SEGMENT OVERVIEW 82
TABLE 65 BECTON, DICKINSON AND COMPANY: KEY DEVELOPMENTS 82

FIGURE 1 GLOBAL DENTAL SLEEP MEDICINE MARKET BY TREATMENT AND DIAGNOSTICS, 2016 (% MARKET SHARE) 10
FIGURE 2 GLOBAL DENTAL SLEEP MEDICINE MARKET BY TREATMENT, 2016 (% MARKET SHARE) 11
FIGURE 3 GLOBAL DENTAL SLEEP MEDICINE MARKET BY DIAGNOSTICS, 2016 (% MARKET SHARE) 11
FIGURE 4 MARKET STRUCTURE OF GLOBAL DENTAL SLEEP MEDICINE MARKET 13
FIGURE 5 RESEARCH PROCESS OF MRFR 14
FIGURE 6 PORTER FIVE FORCES ANALYSIS OF GLOBAL DENTAL SLEEP MEDICINE MARKET 17
FIGURE 7 DROC OF GLOBAL DENTAL SLEEP MEDICINE MARKET 20
FIGURE 8 GLOBAL DENTAL SLEEP MEDICINE MARKET, BY TREATMENT AND DIAGNOSTICS, 2016 & 2023
(USD MILLION) 28
FIGURE 9 GLOBAL DENTAL SLEEP MEDICINE MARKET, BY END USERS 2016 & 2023 (USD MILLION) 31
FIGURE 10 GLOBAL DENTAL SLEEP MEDICINE MARKET, BY REGION, 2016 & 2023 (USD MILLION) 34
FIGURE 11 NORTH AMERICA DENTAL SLEEP MEDICINE MARKET, BY COUNTRY MARKET SHARE 2015 (%) 35
FIGURE 12 EUROPE DENTAL SLEEP MEDICINE MARKET, BY COUNTRY MARKET SHARE 2016 (%) 40
FIGURE 13 ASIA PACIFIC DENTAL SLEEP MEDICINE MARKET, BY COUNTRY MARKET SHARE 2016 (%) 51
FIGURE 14 MIDDLE EAST AND AFRICA DENTAL SLEEP MEDICINE MARKET, BY COUNTRY MARKET SHARE 2016 (%) 62
FIGURE 15 KONINKLIJKE PHILIPS N.V.: RECENT FINANCIAL 69
FIGURE 16 KONINKLIJKE PHILIPS N.V.: GEOGRAPHICAL MIX 69
FIGURE 17 KONINKLIJKE PHILIPS N.V.: OPERATING SEGMENTS 70
FIGURE 18 KONINKLIJKE PHILIPS N.V.: SWOT ANALYSIS 71
FIGURE 19 RESMED: RECENT FINANCIAL 72
FIGURE 20 RESMED: SWOT ANALYSIS 73
FIGURE 21 FISHER & PAYKEL HEALTHCARE: RECENT FINANCIAL 74
FIGURE 22 FISHER & PAYKEL HEALTHCARE: SWOT ANALYSIS 75
FIGURE 23 DRIVE DEVILBISS HEALTHCARE: SWOT ANALYSIS 77
FIGURE 24 CURATIVE MEDICAL INC.: SWOT ANALYSIS 79
FIGURE 25 BECTON, DICKINSON AND COMPANY: RECENT FINANCIAL 82

 

Scroll